4-Bromo-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Catalog No. :
ACKQNE278
CAS No. :
1402172-59-1
Molecular Formula :
C12H17BBrNO2
Molecular Weight :
297.99

IUPAC Name:4-bromo-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

4-Bromo-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
IUPAC Name4-bromo-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Molecular FormulaC12H17BBrNO2
Molecular Weight297.99
SMILESCC1(C)C(C)(C)OB(C2=CC(Br)=CC(C)=N2)O1
InChI KeyLETMYWBGWXISKV-UHFFFAOYSA-N
Synonym4-Bromo-6-methylpyridine-2-boronic acid pinacol ester;Pyridine, 4-bromo-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1402172-59-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKQNE278 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACVOHT471 route compound structure diagram
    ACVOHT47179055-52-0 In Stock
  4. Then
  5. ACKQNE278 route product structure diagram
    ACKQNE2781402172-59-1
Inquiry

2. ACKQNE278 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKQNE278 route product structure diagram
    ACKQNE2781402172-59-1
Inquiry

Comments (0)